Good Food Institute: Top Climate Nonprofit Evaluation 2026
Summary
- What is the Good Food Institute?
The Good Food Institute (GFI) is a nonprofit that seeks to make alternative proteins (alt proteins) competitive with conventional proteins in terms of taste and price. Launched in 2016, GFI is headquartered in the U.S. and has independent affiliate offices in the Asia-Pacific region (based in Singapore), Brazil, Europe, India, Israel, and Japan.
- How could GFI address climate change?
Livestock produces about 11-17% of all global greenhouse gas emissions, and about 42-65% of all emissions from the food system. Livestock emissions include direct emissions from livestock, such as methane release from cows, and indirect emissions, such as those caused by land use change. Reducing livestock production is an important lever for driving down emissions and could also free up some land for carbon sequestration. We think that GFI’s work to make alt proteins equal to or better than conventional meat could make alt proteins the default choice for more consumers, resulting in fewer food system emissions.
- How could GFI address biodiversity loss?
Animal agriculture requires substantial land use, and global meat consumption is set to increase. Out of all habitable land, nearly half (45%) is used by agriculture, of which 80% is used by animal agriculture despite accounting for the minority of global calorie and protein supply (17% and 38%, respectively). Land-use change is the main driver of terrestrial biodiversity loss because it reduces natural habitats. By lowering livestock production and the land it requires, GFI’s work to make alternative proteins the default can therefore help reduce future habitat loss.
- What does GFI do?
GFI has three focus areas: science, policy, and industry. Its science-focused activities advance open-access research in alt proteins and support a research and training ecosystem. Its policy workstream advocates for fair policies and public research funding for alt proteins. Its industry work develops partnerships with companies and investors to drive investment and support innovation.
- What has GFI accomplished historically?
We think GFI’s advocacy has helped increase public funding for alt protein research and development, such as the $510 million USD that governments committed to alt proteins in 2024, and the inclusion of alternative proteins in major biotech funding commitments in 2025 and 2026. GFI has also worked with governments to develop alt protein strategies and regulatory frameworks. Furthermore, it achieved victories in several labeling law initiatives and established a talent and training network under its Alt Protein Project.
- What is new at GFI in recent years?
GFI added significant wins to its track record between 2024 and 2026. Highlights include regranting several million USD to alt protein research; making cell lines for cultivated meat available to academia; the inclusion of alternative proteins in Germany’s Biotechnology Roadmap; its partnership with the Bezos Earth Fund, which unlocked $100 million of funding for three global alt protein research centers; engagement with Singapore’s Islamic council on the ruling that cultivated meat can be halal; and opening a new office in Japan. Its ongoing work includes continued wins unlocking millions of dollars of public funding for alt protein innovation globally, securing support for alt proteins as national priorities, and challenging several cultivated meat bans in Europe and the U.S.
- What is GFI’s cost-effectiveness?
We developed a cost-effectiveness analysis (CEA) in 2022—with a light update in 2024—as a rough plausibility check. We estimated the cost-effectiveness of GFI’s historical work increasing funding for alt protein research and development and its impact on reducing emissions, in expectation. We use this outcome as a proxy for the cost-effectiveness of a donation to GFI in 2025 or 2026. Overall, we estimate that GFI is highly cost-effective. We have low confidence in this CEA, but generally view it as a positive input to our overall assessment of GFI.
We did not conduct an analysis of GFI’s cost-effectiveness for reducing biodiversity loss, since there is no straightforward variable of interest. However, since GFI uses the same strategy to address both climate change and biodiversity loss, and because we have a favorable view of GFI’s cost-effectiveness for climate change mitigation, we expect that GFI is also highly cost-effective as a biodiversity nonprofit.
- Is there room for more funding?
While GFI has been able to attract substantial funding from climate and animal welfare grantmakers, it has not yet met its fundraising goals for 2026 and 2027. As of October 2026, the organization still aims to fundraise $18.9 million for 2027 to continue its existing operations. If GFI meets or exceeds its fundraising goals, it can increase the growth of its recently launched work in Korea and Japan, continue or increase capacity for national-level policy work in Europe, and expand the scale of its research grants program.
- Are there major co-benefits or potential risks?
We think GFI’s co-benefits and potential risks are tied to those of alt proteins. Co-benefits of alt proteins include improved farm animal welfare, improved food security, reduced antimicrobial resistance and risk of zoonotic disease, and reduced risk of chronic disease from meat consumption. At the same time, there is uncertainty about the impacts of the workforce transition that may result from a major shift away from traditional livestock production.
- What are the key uncertainties and open questions?
Key uncertainties include how rapidly alt proteins can improve in taste and price, how social and cultural dynamics will influence the consumer acceptance of cultivated meat, and the scalability of cultivated meat. These factors all affect the extent to which alt proteins can displace meat and reduce livestock emissions.
- What is the bottom line, and what are the next steps?
We classify GFI as a Top Climate Nonprofit as well as a Top Biodiversity Nonprofit. We are impressed by GFI’s ability to position alt proteins as an innovation priority, accelerate research and development, and secure government support for plant-based and cultivated meat. We plan to continue assessing our key uncertainties and believe we will be able to substantially improve our understanding of their severity and importance as GFI executes its strategies in 2027.
This is a non-partisan analysis (study or research) and is provided for educational purposes. Unless otherwise cited, information in this nonprofit evaluation comes from direct correspondence with GFI.
GFI is a registered nonprofit in the U.S. GFI has 501(c)(3) and 501(c)(4) entities. As Giving Green is itself a charitable, tax-exempt organization, we are only offering an opinion on the charitable activities of GFI’s 501(c)(3) arm.
We have evaluated GFI as a Top Climate Nonprofit and a Top Biodiversity Nonprofit. This report covers our thinking about GFI as both a climate change nonprofit and as a biodiversity nonprofit. We last updated our evaluation of GFI’s work to address climate change in 2026. We first evaluated GFI’s work to address biodiversity loss in 2025 as part of a consulting project applying our experience evaluating climate change strategies and nonprofits to biodiversity.
Questions and comments are welcome at hello@givinggreen.earth
What Is the Good Food Institute?
The Good Food Institute (GFI) is a 501(c)(3) nonprofit organization launched in 2016. It seeks to make plant-based, cultivated, and fermented alternative proteins (alt proteins) competitive with conventional proteins in terms of price and taste.1 GFI aims to transform consumption patterns by making alt proteins a default choice.
GFI is headquartered in the U.S. and has independent affiliate offices in the Asia-Pacific region (based in Singapore), Brazil, Europe, India, Israel, and Japan.2 GFI chooses its locations based on total government funding for research and development (R&D), strong research ecosystems, and potential for corporate engagement. Giving Green has recommended GFI as a Top Climate Nonprofit since 2022 and as a Top Biodiversity Nonprofit since 2026.
-----
1 GFI has 501(c)(3) and 501(c)(4) entities, however, its (c)(4) entity is not funded or staffed. As Giving Green itself a charitable, tax-exempt organization, we are only offering an opinion on the charitable activities of GFI’s 501(c)(3) arm, and not on GFI’s 501(c)(4) entity. “In 2016, the year GFI was founded, we launched two alt protein startups and accelerated alternative protein innovation in the public and private sectors.” GFI, 2016.
2 “GFI advances critical work not just in the United States, but also through our affiliates in the Asia Pacific, Brazil, Europe, India, Israel, and Japan.” GFI, n.d.
How Could GFI Help Address Climate Change and Biodiversity Loss?
Key ideas: GFI’s strategy
- Livestock is a major contributor to climate change, responsible for 11-17% of global emissions and 42-65% of food system emissions, primarily from land use change, enteric methane, and manure management. Decarbonizing other sectors will not reduce livestock emissions, and emissions are expected to rise with population growth and increased meat consumption in low- and middle-income countries.
- Land use change from natural habitats to agriculture is the leading driver of global biodiversity loss. Animal agriculture dominates agricultural land use, occupying 80% of farmland while providing only 17% of calories and 38% of protein globally.
- We think alternative proteins can be a critical lever to reduce habitat loss, protect biodiversity, and reduce food system emissions by reducing meat consumption and mitigating land use change.
- GFI advocates for alternative proteins to be as tasty, affordable, and accessible as conventional meat by working with scientists, policymakers, and industry. We think its approach of supporting R&D, securing public funding, and creating a clear path to market for alt proteins could reduce demand for conventional meat and lower livestock production and emissions.
Alternative Proteins as a Solution to Climate Change
The production and consumption of meat and other animal products is a considerable cause of climate change. Livestock emissions represent 11-17% of global emissions and 42-65% of food system emissions.3 Importantly, energy use represents a very low share of these emissions; most food system emissions instead come from land use change, enteric methane, and manure management.4 Therefore, we cannot expect progress in other parts of the economy, such as power grid decarbonization, to lead to material reductions in livestock emissions. The climate impact of livestock farming is expected to increase as the world’s population grows and as low-income countries become wealthier and consume more animal products.5
We think reducing livestock production could be an important lever for driving down emissions and could potentially free up some land for carbon sequestration.6 In our sector report on food, agriculture, and land, we selected scaling alt proteins as our priority strategy to address these emissions. Our Scaling Alternative Proteins strategy report describes our approach to scaling this sector in more detail.
Alternative Proteins as a Solution to Biodiversity Loss
As we describe in our strategy report on reducing biodiversity loss, land use change from natural habitats to (mainly) agriculture is the most dominant driver of global biodiversity loss. Out of all habitable land, nearly half (45%) is used by agriculture, of which 80% is used by animal agriculture, despite accounting for the minority of global calorie and protein supply (17% and 38%, respectively).7 Animal products require much more land per gram of protein and per calorie than plant-based sources of food, driving this imbalance.
Almost all (approximately 95%) of deforestation, an important type of land use change, occurs in the tropics. The main economic driver of deforestation is conversion to cattle pastures—accounting for 41% of all deforestation—followed by oilseed cultivation, including soybeans for animal feed.8
Our strategy report on reducing biodiversity loss explains that achieving plant-rich diets globally is one of the most important levers to prevent additional habitat loss by 2050. In line with our approach to reducing food system emissions, we think that advocating for alt protein policy and research could be a promising intervention for reducing (animal-based) meat consumption.
GFI’s Strategies
GFI has three focus areas: building a scientific ecosystem, advocating for supportive policies, and engaging with the food industry. A description of its focus areas follows:
- Science: GFI advances open-access research in alt proteins and supports a research and training ecosystem. Specifically, GFI identifies research gaps, publishes white papers and reviews of research gaps, regrants funding to fill research gaps, advocates for open-access research, and convenes scientists to advance R&D. GFI delivers catalytic grants that enable early data collection, which helps scientists outside of GFI apply for subsequent grants and de-risks research areas. Additionally, GFI’s science team provides scientific consultation to other philanthropic and government grantmakers and supports investigators in crafting high-impact proposals. It also helps develop a talent pipeline for alt protein R&D by establishing university courses and providing guidance on forming startups.
- Policy: GFI advocates for fair policies and public research funding for alt proteins. Increasing global government R&D funding for alt proteins is GFI’s main policy priority. Its policy activities include advocating for increased R&D funding for alt proteins, campaigning for fair label laws, challenging cultivated meat bans, and establishing a clear path to market for cultivated meat. It works closely with policy organizations on legislative work, such as strategizing on what to prioritize and when.
- Industry: GFI partners with companies and investors to drive investment and support innovation. Its corporate engagement includes supporting alt protein startups and building relationships with large agri-food companies and investors to encourage them to invest in alt proteins. It also conducts market research to develop reports and white papers that it shares with industry stakeholders to support the alt protein sector as a whole. Additionally, it works with food retailers to grow their alt protein sales and advises restaurants and foodservice distributors on improving plant-based food marketing and menu options.
Of these focus areas, GFI spends most of its funding on its science workstream, which includes regranting. Its policy workstream receives the second most funding.
-----
3 “In short, livestock production appears to contribute about 11%–17% of global greenhouse gas emissions” The Breakthrough Institute, 2023; total agricultural emissions: “Food production accounts for over a quarter (26%) of global greenhouse gas emissions.” Our World in Data, n.d. Calculation: 11/26 = 42% and 17/26 = 65%, hence 42-65% of agricultural emissions
4 On-farm energy use is a small amount of total food system emissions in Table 1 Tubiello et al., 2021; largest sources of food system emissions: Figure by Our World In Data, 2019 based on data from Poore and Nemecek, 2018
5 “...demand for animal-based foods, coupled with the rapid urbanization in sub-Saharan Africa and South Asia and the income growth in low and mid-income countries, is projected to increase by nearly 70 percent.” FAO, 2023
6 Sources of livestock emissions: Sources include land conversion to accommodate animal grazing and crop production, methane emissions from ruminants (e.g., cattle), and manure management. Importantly, cattle production is a major driver of deforestation, which releases stored carbon into the atmosphere. Carbon sequestration: “Here we quantify the total carbon opportunity cost of animal agricultural production to be 152.5 (94.2–207.1) gigatons of carbon (GtC) in living plant biomass across all continents and biomes. We approximated the potential for CO2 removal in soil and litter as an additional 63GtC” Hayek et al 2020.
7 Figure 1, Ritchie & Roser, 2023
8 We base this on a summary by Ritchie (2021) of Pendrill et al. (2019).
GFI’s Theory of Change
We constructed a theory of change that reflects our understanding of how GFI’s activities can reduce food system emissions (Figure 1). This theory of change focuses on making alt proteins more taste- and price-competitive with conventional meat by supporting alt protein R&D, securing public funding for R&D, and ensuring alt proteins have a clear path to market.9 We believe this approach could help displace some demand for conventional meat and eventually reduce livestock production and its associated emissions. We examine the evidence for how well GFI executes its inputs in the sections below.

We also constructed a theory of change that reflects our impression of how GFI’s activities can reduce meat consumption and therefore avoid the expansion of pastures and croplands for animal feed (Figure 2). This theory of change is mostly identical to our theory of change for how GFI could reduce greenhouse gas emissions, because in both cases, the overall aim is to reduce the global consumption of conventional meat.
Our theory of change for how GFI can address biodiversity loss also includes tackling climate change. Since climate change itself is a mid-level driver of biodiversity loss, we think that GFI’s contributions to decarbonizing the food system is a non-negligible contributor to reduced biodiversity loss.
The biodiversity-relevant theory of change excludes GFI’s work on cultivated seafood. While we have a generally positive view of GFI’s seafood work, we primarily focus on terrestrial biodiversity in this Nonprofit Evaluation. We did not evaluate GFI’s efforts to advance cultivated seafood.

Assessment of GFI’s Ability to Execute Its Activities
Science: Building A Scientific Ecosystem
We have a positive impression of GFI’s ability to catalyze research funding for alt proteins. Since 2019, GFI has awarded 129 grants across 25 countries to support open-access research, totaling over $27 million USD.10 Some of its grant funding has also catalyzed follow-on government funding.11
GFI has also been successful in building a talent pipeline for alt protein research. Since 2025, 28 new university groups joined GFI’s Alt Protein Project, which aims to introduce alt protein research to students and faculty.12 In total, GFI’s Alt Protein Project has established student groups in 109 universities, of which 78 are currently active.13 GFI's grants and commissioned research aim to make knowledge about alt proteins freely accessible to everyone, especially when it might otherwise be held as private intellectual property.
We also believe GFI has demonstrated strong partnership-building and resource-leveraging capabilities. In 2024, GFI expanded its research footprint by partnering with the Bezos Earth Fund (BEF) to scope and select global centers for alt protein science and innovation. As part of this process, GFI initially provided 14 universities with funding to draft proposals for becoming alt protein research centers. The Bezos Earth Fund then provided seed funding to three of the universities with $30 million each to develop research centers.14 GFI assisted the selected universities in securing additional funding (a requirement of the BEF grants) and helped several non-selected applicants apply for government funding to open their own centers.
GFI has also played a role in ensuring open-access science. In 2025, GFI acquired the cell lines and serum-free cultivated meat serum formulations, which typically cost millions of dollars to develop, of the defunct startup SCiFi Foods.15 GFI is making these cell lines and formulations available to academia and—in a later stage—to industry.16 In 2026, GFI acquired three new cell lines and is exploring a pipeline of deals with other companies that are ceasing operations to build out its acquisition portfolio.
Policy: Agenda-Setting and R&D Funding
GFI’s advocacy has helped increase public funding for alt protein R&D. Government funding for alt protein R&D reached $510 million in 2024. Since then, governments have supported alt protein innovation largely through broader biotech programs and blended finance.17 We think these advocacy wins are likely shared between GFI and many other organizations, although we think GFI has been a key driver and convener. For example, to the best of our knowledge, GFI was the only nonprofit organization that played a role in the states of California and Illinois allocating $5 million each to alt protein research in 2022 and 2024, respectively.18 It was also among the only two nonprofit organizations that assisted with the $5.5 million federal budget allocated to the U.S. Department of Agriculture for alt protein research.19
We think GFI’s U.S. federal policy engagement has helped elevate alt proteins as a research priority by driving the creation of coordinated U.S. government initiatives and long-term R&D planning. GFI was involved in the creation of an interagency working group to coordinate alt protein R&D through the U.S. government.20 It also contributed to the establishment of alt proteins as one of the seven key themes for CASA-Bio, a federal bioeconomy R&D initiative.21 Although the executive order that prompted CASA-Bio was revoked in March 2025, we think that GFI could continue to advance R&D vehicles in the future pending a more favorable policy environment.
Furthermore, GFI plays a key role in identifying and socializing research funding opportunities. For example, GFI’s Public Investment and Industry Initiative aims to raise public capital to build the infrastructure required to scale production in the absence of sufficient venture capital. In practice, the initiative shares available grant and loan opportunities with the sector. GFI estimates that, since 2024, this work has influenced $59.7 million in funding to alt protein companies, based on testimonials by alt protein companies.22
In the U.S., GFI has good working relationships with partners across the executive and legislative branches of the government, which we think increases the likelihood of its success. For example, we think GFI’s relationships at the U.S. Department of Agriculture (USDA) most likely helped convince the agency to allocate $10 million to Tufts University to develop the world’s first national center for cellular agriculture. We note that GFI’s longtime chief of staff left the organization to serve as the Deputy Undersecretary for the division of USDA that made the grant. Additionally, the center director at Tufts, David Kaplan, credits GFI’s scientific ecosystem building with catalyzing the application, meaning GFI likely played a part both in the center’s application and eventual approval.23
Outside the U.S., GFI has also influenced governments to set alt proteins as priorities in national food and bioeconomy strategies.24 Examples include:
- Israel: According to GFI, the Israeli government will use GFI Israel’s Alternative Proteins National Policy Plan as a roadmap for its national foodtech policy plan.
- India: In 2024, GFI was part of the Indian Science Ministry’s sectoral committee on smart proteins, whose proposals led to alt protein being a key focus area for the government's new national Bioeconomy Policy. GFI India staff helped review alt protein scientific research proposals.25
- United Kingdom: In 2024, the U.K. government announced a £15 million GBP National Alternative Protein Innovation Centre after GFI Europe’s multi-year engagement with the U.K.’s public research funder (UK Research and Innovation). GFI Europe also claims to have played an important role in the post-Brexit regulatory sandbox for novel foods, which helps draw investment and streamline regulatory approval.26
- Germany: In 2025, Germany’s Scientific Advisory Board on Agricultural Policy, Nutrition and Consumer Health released a favorable report about the potential of alt proteins, which extensively cited GFI and called for increased research and scaling funding for alt proteins, as well as clear regulatory paths to approval.27 In 2026, the country’s biotechnology roadmap included plans for a national innovation hub for cultivated meat and precision fermentation as well as several plans to streamline the path to market.28
- Brazil: In 2026, Brazil’s Ministry of Finance included alt proteins for the first time in a program offering up to R$7.5 billion BRL ($1.46 billion USD) to commercialize Brazilian research.29 GFI Brazil claims that it secured the sector’s inclusion and works to connect companies to this opportunity.
We also believe that GFI has been able to bring attention to alt protein policy on a global stage. In 2023, GFI increased its efforts to promote alt proteins as a climate solution worldwide. For example, GFI collaborated with a coalition of organizations, including major climate funders and nonprofits, with the common objective of highlighting the significance of alt proteins as a climate solution in international discussions. We think these activities are indicative of GFI’s convening power, which we also believe strengthens its policy advocacy.
GFI had a notable presence at the Consultative Group on International Agricultural Research / Food and Agriculture Organization of the U.N. (CGIAR/FAO) pavilion at COP29 and GFI’s founder has joined the advisory board of the EAT Foundation, which is responsible for the work of the EAT Lancet Commission. We have also heard of the direct influence that GFI has had in encouraging at least one climate nonprofit to start an alt protein workstream.
Policy: Regulatory Approval and Labeling Laws
We believe that GFI’s work at the legislative, executive, and judicial levels has helped defeat some of the label laws in the EU and U.S.30 Policymakers in various countries have introduced bills restricting alt protein producers from labeling their products with meat and dairy terms, protecting the interests of livestock producers and potentially reducing alt proteins’ competitiveness. GFI’s legal wins in 2023 and 2022 include the narrowing of a Louisiana state law prohibiting companies from using meat-related terms on alt proteins and a ruling declaring a similar Arkansas state law as unconstitutional.31 As of late 2025, GFI had helped defeat 12 U.S. state cultivated meat sales bans and has successfully advocated for removing research bans in Florida and Texas in cultivated meat bills, along with coalition partners from the private sector.
We think GFI has also helped clarify the pathway of cultivated meat to market. For example, GFI directly advocated for USDA and the U.S. Food and Drug Administration (FDA) to use standard processes applicable to conventional meat products in the existing regulatory system. GFI also promoted the establishment of fair labeling requirements when the agencies were building their regulatory strategy for cultivated meat.32 We think using an existing regulatory framework has helped cultivated meat come to market sooner and could help boost consumer confidence, while giving USDA authority over labeling could help guard against delayed approval due to state-level labeling requirements.33
We think GFI’s work helped accelerate approvals of cultivated meat. For example, in November 2022, GFI was featured in substantial media coverage related to the U.S. FDA’s first-ever approval of cultivated meat. We think this media coverage is indicative of the regulatory expertise and advocacy that GFI has brought to the alt protein sector.34 Between 2023 and 2025, more cultivated meat and fish products have been approved for sale in the United States, Singapore, and Australia.35 According to GFI, it also played a substantial role in developing Brazil’s regulatory frameworks for cultivated meat and fermentation-derived alt proteins, which were published in 2023.36 GFI is also the only alt protein-focused official observer in the Codex Alimentarius Commission (CAC), a U.N. food standards body. It contributed technical input on assessing the safety of cultivated meat media ingredients. The CAC’s food additives committee has not yet reached a decision on this topic, so we will continue monitoring GFI’s impact as part of the working group formed to refine the proposal.37
GFI provided technical presentations to support Islamic religious rulings (fatwas) that cultivated meat can be halal. In 2024, the Islamic Council of Singapore made the first-ever authoritative decision that cultivated meat can be halal.38 According to GFI, this came after over a year of deliberation, during which GFI provided numerous inputs.39 The ruling was announced at an invite-only conference featuring a GFI speaker.40 We think this is indicative of GFI’s role as a trusted contributor to the council’s decision. In 2025, Malaysia’s Islamic authority issued a similar statement after GFI staff provided technical presentations about the science of cultivating meat from animal cells.41
Industry: Corporate Engagement
We think GFI’s engagement with large food companies helps scale alt proteins and reduces support from existing meat suppliers. GFI’s strategic support to industry actors was acknowledged by JBS—the largest protein company in the world—when JBS announced its $100 million commitment to cultivated meat.42 In addition to spurring innovation, this commitment could expand cultivated meat production because JBS can produce and distribute more goods at scale than smaller competitors can. Additionally, we think building an alliance with the largest meat producer in the world could decrease industry opposition or concern about the progress of alt proteins.
GFI is also developing new vehicles to stimulate institutional demand and an open-access platform to train predictive AI models for taste and texture optimization.
Because corporate engagement is a minor part of GFI’s work and our strategy report on alternative proteins primarily focuses on science and policy, we did not assess GFI’s corporate engagement efforts in depth.
Examining the Assumptions Behind GFI’s Theory of Change
Below, we evaluate the main assumptions behind our understanding of GFI’s theory of change and rate our certainty in each as low, medium, or high.43 Our ratings rest on primary and secondary evidence and our general impression of each assumption’s plausibility. Importantly, many stages of GFI’s theory of change are difficult to measure, lack a robust evidence base, or have not yet occurred.
- Replacing conventional meat products with alternative proteins substantially reduces greenhouse gas emissions (high certainty)
We have high certainty that directly substituting some alt proteins for their conventional meat counterpart would substantially reduce greenhouse gas (GHG) emissions. Substituting some conventional meat with alt proteins may reduce emissions by lowering direct emissions from livestock farming and curbing emissions from land use change.44 As shown in Figure 3, the range of greenhouse gas emissions per kg of product is much lower for plant-based meats than for beef, pork, and most chicken products.45

How the emissions from cultivated meat compare to conventional meat will depend on its energy source. While cultivated meat requires a substantial amount of energy, its emissions can be reduced by 70% (to ~4.0kg CO2e per kg) if manufacturers use renewable energy at their facilities.47 Since cultivated meat is expected to develop alongside a renewable energy transition, we are optimistic that its carbon footprint can be lower than most forms of conventional meat production by the time it reaches significant scale.48
Because alt protein production is still in its early stages, it is impossible to predict with certainty what its future production and GHG emissions will look like. However, it seems highly likely that investing in alt protein R&D will shift alt protein improvements and GHG reductions forward in time relative to the counterfactual. We will continue to monitor developments in alt protein production and will update our thinking with new information.
- Directly substituting some alt proteins for their conventional meat counterpart would substantially reduce biodiversity loss (high certainty)
We have high certainty that substituting some conventional meat with alt proteins reduces habitat loss. Plant-based protein sources require substantially less land per unit of protein than animal-based protein sources, especially when compared to lamb, beef, and cheese. Common protein sources in plant-based meat products—such as soy, wheat, and peas—have land footprints that are several units of magnitude less land-intensive than beef (Figure 4).49 Since other inputs to creating plant-based meat (e.g., energy and spices) require negligible amounts of land, plant-based alt protein products generally require less land than their conventional counterpart, according to several life cycle analyses (LCAs) highlighted in Figure 5.50


Cultivated meat also has a substantially reduced land requirement relative to beef and other types of meat. Figure 6 is based on a prospective LCA of cultivated meat production in 2030 and only includes the land requirement for croplands for cattle feed. We expect that the actual difference between cultivated meat and beef is even larger, since cultivated meat does not require pastureland, while conventional beef often does.

Our strategy report on reducing biodiversity loss describes in more detail how plant-rich diets are an important lever to prevent the future expansion of croplands and its associated habitat loss.
One important nuance is that the average land requirements of alt proteins do not account for where land use change is prevented. To maximize biodiversity benefits, we should especially reduce land use change in biodiversity hotspots, such as wetlands and rainforests. The vast majority (71%) of deforestation-related carbon emissions come from food consumed in the country where it was produced.54 Therefore, to tackle deforestation in the tropics, an important lever could be to reduce meat consumption in tropical countries consuming high quantities of beef. Trade models list countries that produce high quantities of beef and soy—such as Brazil and Indonesia—among the countries with the highest per capita CO2 emissions from deforestation, alongside high-income countries such as Luxembourg, Taiwan, Belgium, and the Netherlands.55
We believe that GFI addresses the trade-relevant aspects of deforestation and land-use change appropriately for three reasons:
- GFI focuses most of its corporate engagement on high-income countries. Since high-income countries have—when accounting for trade—some of the highest food-related deforestation rates per capita, addressing meat consumption in these countries is most important on the margin. GFI’s corporate engagement includes work in high-income countries in North America and Europe.
- A large part of GFI’s budget is dedicated to science and technology. GFI’s theory of change focuses in part on accelerating alt protein R&D to improve the taste, price, and convenience of alt protein products. This work has potential for a global spillover, including to biodiversity hotspots like Brazil and Southeast Asia.
- GFI has affiliate organizations in Brazil and the Asia-Pacific region. GFI Brazil and GFI Asia-Pacific work on, among other strategies, the adoption of alt proteins and supportive policies in tropical regions.
- Making alt proteins more taste- and price-competitive with conventional proteins will displace some demand for conventional proteins (medium certainty)
Studies find that taste and price are the two main drivers of consumer food choices, with nutrition and texture playing an important role.56 Barriers differ by the type of alt protein: U.S. survey data suggest price weighs more heavily for plant-based meat, while perceived unnaturalness, wanting to support farmers, and lack of understanding are more prominent for novel alt proteins.57 They also differ by geography. For example, survey participants in India and China reported significantly higher acceptance for alt proteins in general than those in the U.S., though higher familiarity predicted higher acceptance across all countries.58
In U.S. surveys across plant-based meat, cultivated dairy, cultivated meat, and mycoprotein, consumers cited taste and texture as the primary barrier to adoption for every category except cultivated meat, where it was perceived unnatural-ness.59 We think the surveys on novel proteins likely underweight price, and that revealed preferences would show greater price sensitivity, especially for recurring purchases. This is because a) food choices are generally highly price-sensitive, b) the question was framed as a one-time try or buy rather than a repeat behavior, and c) it was posed only to those already unlikely to try novel proteins, who plausibly hold stronger ideological objections than more open consumers.
Empirical evidence shows price can shift alt protein demand in the right contexts. When the German supermarket Lidl brought its plant-based range to price parity, sales rose by over 30%.60 We think Europe is especially open to adopting plant-based products, with meat consumption per capita now decreasing in some European countries, so we are uncertain if this result is replicable globally.61 Across four U.S. consumer trials, cutting the price of plant-based burgers raised selection by 3 percentage points among regular meat eaters and 6 points among those on alternative diets.62 However, at price parity consumers still chose meat more often, and on average were willing to pay $1.11 more for a beef meal than a plant-based one.63 We are unsure how this would change if the products were also at taste-parity.
Outside of taste and price, various social and cultural dynamics also influence the number of people open to trying alt proteins. For example, trends of alt proteins being perceived as unnatural or unhealthy, right-wing opposition to cultivated meat in the U.S., and meat as a symbol of social status, can all lead to fewer people being open to eating alt proteins.64 Alongside taste and price, supportive regulation, positive health perceptions, and a favorable social environment have been cited as conditions for alt proteins to reach large market share.65
Our current conclusions are that:
- Taste and price are two of the most important factors influencing consumer protein choices.
- Taste and price improvements can increase alt protein demand on the margin, but reaching parity is unlikely to be sufficient for a substantial share of consumers.
- Motivations vary substantially across markets, geographies, and alt protein types.
- There are several other factors that influence consumer protein choices, and we are not sure how much of a barrier they will present, should alt proteins reach taste- and price-parity.
Because of the uncertainty in the current evidence-base, we will continue to monitor this space to update our views. In particular, the global evidence base is still relatively sparse. We also note that the evidence base for taste-parity is less certain than price-parity, since there is an insufficient availability and range of products on the market for it to be empirically assessed.
- More demand for alt proteins will lead to less demand for meat (medium certainty)
We are unsure whether increased demand for alt protein actually displaces meat, since consumers may choose to consume both alt proteins and meat. For example, a study on alt protein buying patterns found that ~86% of alt protein buyers also buy meat, though they spent ~13% less on meat than their non-alt protein buying counterparts.66 Another study on the effect of promoting plant-based products in supermarkets found that although this led to greater sales of plant-based products, there was no corresponding reduction in meat sales.67 Different meats have also been shown to have different sensitivities to substitution. For example, reducing the price of Beyond Meat was shown to have a greater reduction in chicken consumption than beef consumption.68
Our conclusion from these studies is that alt proteins substitute for some animal products, but are not a one-to-one substitute. We think that substitution rates will be higher for products that more closely mimic animal products, such as cultivated meat, compared to plant-based meat. We will continue to monitor the evidence-base to update our views.
- Alt protein-related legislation will continue to pass under a more conservative U.S. government (medium certainty)
Because the U.S. is currently a leader in alt proteins and because most of GFI’s work is focused on the U.S., we think it is important to consider whether GFI can continue to achieve policy wins in the U.S.
We have medium certainty that alt protein legislation will continue to pass under a more conservative U.S. government.69 Our impression is that alt proteins receive more political support from the left than from the right. Despite this, we are cautiously optimistic that alt-protein-related federal legislation will continue to pass under a conservative U.S. government. Our thinking is based on the fact that alt-protein-related bills have previously been introduced with bipartisan support, and the regulatory framework to approve cultivated meat for sale was developed under a Republican presidential administration.70
GFI is explicitly focused on building bipartisan support. For example, GFI’s principal policy factsheet for legislators includes a pull quote from former Georgia governor and Trump agriculture secretary Sonny Perdue.71 GFI works to position alt proteins as a national security issue, having collaborated with the National Defense Industrial Association on a research brief on the benefits of alt proteins for security and supply chain resilience.72 The book Meat by GFI president Bruce Friedrich contains a chapter on the importance of U.S. leadership in alternative proteins and its Republican support, which was covered by Foreign Policy.73 Additionally, GFI engages with state-level and executive-branch policymakers (e.g., at the Departments of Agriculture and Energy and the National Science Foundation), offering other avenues for getting alt protein policies passed and research funded. We think GFI’s explicit focus on bipartisan support increases the probability of pro-alt protein legislation being introduced and passed under conservative governments.
Since GFI has affiliate offices in six other regions, we think it would continue to make progress in other countries regardless of whether the U.S. policy environment is favorable to alt proteins.
-----
9 Although GFI focuses on improving the taste and price of alt proteins, we believe that funding R&D can also improve alt proteins’ nutritional value, and efforts that support the private sector can improve convenience.
10 "$27M+ in open-access research support, 141 grants awarded since 2019, 26 countries where GFI has funded research." The Good Food Institute, “Alternative protein research grants” n.d., as of October 2026
11 “Dr. Amy Rowat is one of several GFI grantees who secured follow-on government funding after initial grant support from GFI. Of those who received both, GFI’s $1.8 million in grant dollars led to $16.9 million in government support, a nine-fold multiplying effect.” The Good Food Institute, “2022 Mid-Year Impact Report"
12 “Thirteen new university groups join GFI’s Alt Protein Project, a global community of student leaders reimagining our food system.” GFI, 2025
13 GFI, n.d., as of October 2026.
14 “In 2024, a $90 million investment from the Earth Fund enabled three of those centers to successfully launch, with $30 million each for the new Bezos Centers of Sustainable Protein at North Carolina State University, Imperial College London, and National University Singapore.” Bezos Earth Fund, 2024
15 “By making them widely available, they can rescue years of efforts and millions of dollars’ worth of R&D, which would otherwise be lost after company closures. SciFI Foods is a prime example. The firm raised over $40M to develop a hybrid burger featuring 10% cultivated meat” Green Queen, 2026; “Currently, each cultivated meat startup has to spend a significant portion of their funding and time on cell line development, which is estimated to cost between $2-10 million per startup.” GFI, 2025
16 “Developing new cell lines takes time and money, two things the cultivated meat space sorely lacks, says The Good Food Institute (GFI), which has acquired cell lines and serum-free media formulations from defunct startup SCiFi Foods to make them available first to academia and later, the wider industry.” AFN, 2025
17 “We estimated that governments around the world announced about $510 million in new committed support for alternative proteins, including increases in R&D. This brings the all-time cumulative commitment from governments to around $2.1 billion.” GFI, 2025 (previous report)
“Companies in the sector are now receiving government-backed loans, loan guarantees, blended finance, and direct investments in addition to direct grant funding; new research often cuts across multiple technology sectors and product categories; and large commitments to build out biotechnology leadership and biomanufacturing capacity often highlight food production without specifying the exact amount of investment in it.” GFI, 2026 (current report)
18 Illinois funding: “The sum of $5,000,000… to the University of Illinois for costs associated with the expansion of the Integrated Bioprocessing Research Laboratory’s and other related infrastructure improvements.” Illinois General Assembly, 2024
19 California funding for alt proteins: “Of the funds appropriated in this item, $5,000,000 shall be available on a one-time basis for the Berkeley, Los Angeles, and Davis campuses to support research and development of plant-based and cultivated meats.” University of California, Los Angeles, 2022. Appropriations: “Following months of GFI engagement and just days before the end of the 117th Congress in December, a bipartisan group of lawmakers reached an appropriations agreement that includes $5.5 million for the U.S. Department of Agriculture (USDA) to conduct alternative protein research. Building on past appropriations, this publicly funded research will help fill knowledge gaps, optimize input crops, and improve production processes.” GFI, 2022.
20 GFI engages in policy efforts only to the extent that is permitted by the IRS for 501(c)(3) nonprofit organizations.
21 “GFI’s SciTech team played a key role in CASA-Bio synthesis meetings, collaborating with federal R&D agencies to identify mutual interests for a U.S. bioeconomy roadmap. CASA-Bio is a National Science Foundation-led initiative advancing the U.S. bioeconomy through collaborative research and development across federal and non-federal Organizations.[...] GFI will work with CASA-Bio to orchestrate workshops to draft five-year R&D roadmaps for several areas” GFI, 2024
22 We rely on data submitted to us by GFI. Its overview of U.S. government resources for alternative protein companies and its regularly updated list of open U.S. government opportunities for alternative protein commercialization and scale-up are publicly available. This estimate includes just over $5 million that have not yet been paid out by the U.S. government.
23 “USDA awarded the grant as a part of a $146 million investment in sustainable agricultural research projects announced by USDA Secretary Tom Vilsack on October 6. This investment is being made by USDA-NIFA’s Agriculture and Food Research Initiative’s (AFRI) Sustainable Agricultural Systems program — the nation’s leading and largest competitive grants program for agricultural sciences.” GFI, 2021
24 “The selection criteria for the list of 14, determined by the council, evaluated factors such as Israel’s comparative advantages in certain sectors, its strategic needs as a developed country, its strength in R&D and position as a global innovation hub, and whether the specific sector needs government support and has a scientific component. The Ministry of Innovation, Science, and Technology will promote national programs in the prioritized areas and distribute some NIS 180 million ($52.4 million) a year in research grants with significant emphasis on these fields.” (Times of Israel, 2022)
25 “On Saturday, India announced a biotechnology policy focused on the economy and climate, with smart proteins and functional foods – as well as climate-resilient agriculture – among six pillars of the strategy.” Green Queen, 2024; “GFI India is an integral part of the Science Ministry's sectorial committee on smart proteins whose meetings and proposals led to this outcome.” GFI, 2024
26 “Max Jamilly, co-founder of Hoxton Farms, which makes lab-grown pig fat, said the UK regulatory approvals process had improved beyond recognition since Brexit. “It’s the envy of other EU countries who come to visit us to learn how to ‘sandbox’,” he added.“ FT, 2026
“The new funding will enable the FSA [Food Standards Agency] and FSS [Food Standards Scotland] to make informed decisions about product safety and guide companies on how they can effectively demonstrate that their products and processes are safe, in line with the UK’s existing novel foods regulatory framework.” GFI, 2026
27 “A report by the Scientific Advisory Board on Agricultural Policy, Nutrition and Consumer Health (WBAE) at the German Federal Ministry of Agriculture and Food and Regional Identity (BMLEH) calls for an ideology-free dialogue around plant-based, fermentation-based foods, and cultivated meat. It states that these foods have a place at the ‘common table’ alongside traditional plant-based foods and conventional animal-based products.” GFI Europe, 2025
“Against the backdrop of this differentiated but overall positive assessment of alternative products, recommendations for a policy on ‘More choice at the table with alternative products to animal-based foods as a contribution to a more sustainable diet’ are presented below” WBAE, 2025 (translated from German)
28 “Meilensteintitel: Erste bzw. weitere in Deutschland entwickelte Produkte für biotechnologische Lebensmittel aus Präzisionsfermentation oder Zellkultivierung (z. B. Alternativen zu traditionellen Käse-, Ei-, Fleisch- oder Fischprodukten) auf dem Weltmarkt eingeführt.” [Milestone title: First or additional German-developed biotech food products based on precision fermentation or cell cultivation (e.g., alternatives to traditional cheese, egg, meat, or fish products) launched on the global market.] Hightech Agenda Deutschland, 2026
29 “Alternative Proteins: Development, scaling and industrialisation of alternative proteins and functional ingredients through biotechnology, precision fermentation and plant-based platforms” Tesouro Nacional, 2026, p. 12
30 European Union: “The Good Food Institute Europe, a nonprofit working to accelerate plant-based and cultivated proteins, called on national leaders on the Council of the EU to “clear up this mess” and reject restrictions on plant-based dairy products.” GFI Europe, 2020. 2020. U.S.: “Representing Tofurky, The Good Food Institute, the ACLU of Arkansas, and the Animal Legal Defense Fund challenged Arkansas’s label censorship law, asserting that the statute violates the First Amendment.” GFI, n.d.
31 Louisiana: “The U.S. 5th Circuit Court of Appeals ruled a Louisiana state law prohibiting meat terminology on food not derived from animal carcasses can be enforced, but it only applies to companies that are intentionally trying to deceive consumers. Lead plaintiff Tofurky and its co-plaintiffs the Animal Legal Defense Fund and the Good Food Institute said Thursday the ruling is a win for their side because it narrows the law to companies that are overtly seeking to mislead consumers. In an email, Louisiana Commissioner of Agriculture and Forestry Mike Strain said his office is pleased with the decision.” Food Dive, 2023. Arkansas: “The Arkansas state law prohibiting plant-based meat companies from using meat terminology on their product labels and marketing is unconstitutional, a federal judge ruled late last month. The state cannot enforce the law, which has been on the books since 2019, and had been on pause while courts considered this lawsuit from Tofurky, the Good Food Institute, the Animal Legal Defense Fund and the American Civil Liberties Union.” Food Dive, 2023.
32 “USDA and FDA held a joint public meeting on to advance the conversation around clean meat regulation. GFI advocated firmly for a fair regulatory path to market under the existing regulatory structures. Our friends at JUST, Finless Foods, BlueNalu, UPSIDE Foods, and many others joined the conversation as well.” GFI, 2018, plus further correspondence.
33 Consumer confidence: “If people don’t believe that cell-based meat products are safe, regulated, and healthy, then they’ll stick with slaughtered meat… That’s how the cell-based meat industry ended up actively working to convince the US government to step in and exercise its regulatory authority — and that’s why they were encouraged by the government’s announcement.” Vox, 2019. Override state standards: “The USDA’s labelling authority overrides that of the states — states are not allowed to impose labelling requirements incompatible with the standards that the USDA puts forward.” Vox, 2019.
34 “Alongside our advocacy for public investment in alternative protein research, GFI has been working toward regulatory approval for cultivated meat since our founding. In a defining moment for the future of our food system, in November of 2022, the U.S. Food and Drug Administration (FDA) officially gave the green light to a cultivated meat product for the very first time. UPSIDE Foods completed FDA’s rigorous review for its cultivated chicken as part of the agency’s pre-market review process, laying the groundwork for cultivated products to be sold in the United States. GFI was featured in media coverage of this historic milestone in The New York Times, The Wall Street Journal, TIME, The Washington Post, NPR, and more.” GFI, 2022.
35 “A total of seven companies [...] have received regulatory clearance to sell multiple different cultivated meat products: GOOD Meat: cultivated chicken (Singapore and U.S.); UPSIDE Foods: cultivated chicken (U.S.); Vow: cultivated quail (Singapore and Australia); Wildtype: cultivated salmon (U.S.); Mission Barns: cultivated pork fat (U.S.); Believer Meats: cultivated chicken (U.S.); PARIMA: cultivated chicken (Singapore)” GFI, 2025
36 “In 2023, our cultivated meat and fermentation-derived frameworks were officially published by the Brazilian government, signaling an important step toward adoption and implementation.” GFI, 2024
37 “In 2025, the Singapore and China Codex delegations brought a new work proposal to CCFA for the development of guidelines for the food safety assessment of cell culture media components in cell-based food production. [...] GFI joined a working group formed to refine the proposal.” GFI, 2025
“On [cell culture media components], the Committee determined that further consideration is needed and agreed to establish an EWG chaired by Singapore and co-chaired by China and the Republic of Korea, to review the scope of such a guideline, and determine areas where joint FAO/WHO scientific advice would be required to support the work.” CAC, 2026
38 “The Fatwa Committee of the Islamic Religious Council of Singapore (MUIS) announced last week that after conducting extensive deliberations for a year, they have determined that cultivated meat consumption can be considered halal “under specific conditions.” Vegconomist, 2024
39 “This critical decision came after more than a year of deliberations by the Islamic council, during which GFI APAC scientists and policy experts provided numerous technical presentations about the process of cultivating meat from animal cells.” GFI, 2024
40 “MUIS, the only authorized entity in Singapore to issue halal certificates, announced its ruling at an invite-only Fatwa Conference that featured, among other experts, Ph.D. Maanasa Ravikumar, a cultivated meat scientist at the Good Food Institute APAC.” Vegconomist, 2024
41 “According to JAKIM’s fatwa, cultivated meat can be deemed permissible if the source cells are obtained from an animal slaughtered according to Shariah, and if the growth medium and all biological components are derived from halal sources (e.g. no blood serum or other haram substances). [...] “GFI APAC experts have played a supporting role in this deliberative process by providing technical presentations to regional authorities about the science of cultivating meat from animal cells—most recently at the Halal International Seminar in September.” GFI APAC, 2025
42 JBS’ support for cultivated meat: “The deal signals the company’s entry into the cultivated protein market, which consists of producing food from animal cells and includes investment in building a new production plant in Spain to scale up production. Along with the acquisition, JBS is also announcing the setting up of Brazil’s first cultivated protein research & development (R&D) center. In all, JBS will channel US$ 100 million to the two projects.” JBS, 2021. GFI’s support: “JBS' entry into the cultivated protein market had the strategic support of The Good Food Institute, an entity that promotes plant and cell-based alternatives to animal products.” JBS, 2021
43 We describe our certainty as low/medium/high to increase readability and avoid false precision. Since these terms can be interpreted differently, we use rough heuristics to define them as percentage likelihoods the assumption is, on average, correct. Low = 0-60%, medium = 60-80%, high = 80-100%
44 “Animal products—including animal emissions, feed, changes in land use and energy-intensive global supply chains—account for almost 60 percent of food-related emissions (including methane, nitrous oxide and carbon dioxide), for a total of 14.5–20 percent of global emissions… novel ASF [animal source food] alternatives already show strong potential for reduced environmental impacts compared to many conventional animal products.” “life cycle assessment (LCAs) suggest that, compared to conventional beef, they could use 30–50 per cent less energy whilst offering reductions of 86–97 per cent in land use and 67–89 per cent in GHG emissions.” UNEP, 2023
45 “Even the lowest-emitting beef from dedicated beef herds (34 kg carbon dioxide equivalent, or CO2e) and lower-emitting beef from dairy cow herds (15 kg CO2e) came in far above the highest-emitting tofu (4 kg CO2e) and plant-based meat (7 kg). Chicken and pork production emit far less CO2 equivalent than beef. And while there is some overlap (the lowest-emitting chicken [3.2 kg CO2e] and pork [6 kg CO2e] rival the emissions of the highest-emitting plant-based meat), the average emissions of tofu and plant-based meats are still lower than the average emissions of both chicken and pork.” Vox, 2021
46 Figure: Vox, 2021; Data: Poore and Nemecek, 2018 and Santo et al, 2020
48 One study suggests the long term warming of cultivated meat could be higher than conventional beef production in some scenarios due to the length of time CO2, remains in the atmosphere compared to methane (Lynch and Pierrehumbert, 2019). GFI, in response, highlights that it is unlikely that cultivated meat’s energy source in the future will be derived from fossil fuels (GFI, 2019). We agree with GFI’s line of reasoning.
49 Our World in Data, based on Poore and Nemecek, 2018
50 Derived from the overview of the environmental impacts of alternative proteins on the GFI website.
52 Several sources, compiled by GFI (n.d.)
54 Our World in Data, 2024, based on Pendrill et al. (2019)
We think that deforestation-related CO2 emissions are a good proxy for the amount of (tropical) habitat loss.
55 Our World in Data, 2024, based on Pendrill et al. (2019)
56 Figure: ‘Why did lapsed plant-based meat eaters (who ate previously but not in 2024) stop eating plant-based meat?’ GFI, 2025; Figure: ‘Barriers to alt-meat adoption’, Sorrells, 2022. “Among Plant-Based Decreasers that were asked what would make them more likely to consume plant-based, 64% say lower pricing and/or more frequent sales and coupons, and 58% say better taste and/or texture.” Figure 6: ‘Reasons why shoppers are decreasing animal-based food consumption in favor of plant-based foods” Plant-based Foods Institute, 2022; “Of these factors, studies from different countries have consistently identified taste, price, healthiness, and convenience as dominating food choices [...] While some differences have been found in how people prioritise these factors, taste is typically ranked as most important, with the other factors varying in their relative subsequent positions” Dana et al, 2021.; Figure 2 Valli et al., 2022
57 Figure: ‘Why did lapsed plant-based meat eaters (who ate previously but not in 2024) stop eating plant-based meat?’ GFI, 2025; Figure: ‘For Americans who aren’t open to precision-fermented dairy or eggs: what are their barriers?’ GFI, 2025; Figure: ‘For Americans who aren’t open to cultivated meat: what are their barriers?’ GFI, 2025; Figure: ‘For Americans who aren’t open to mycoprotein-based meat: what are their barriers?’ GFI, 2025
58 “We found significantly higher acceptance of clean and plant-based meat in India and China compared to the USA.”; “higher familiarity predicted higher acceptance of plant-based and clean meat across all countries.” Bryant et al., 2019
59 Figure: ‘Why did lapsed plant-based meat eaters (who ate previously but not in 2024) stop eating plant-based meat?’ GFI, 2025; Figure: ‘For Americans who aren’t open to precision-fermented dairy or eggs: what are their barriers?’ GFI, 2025; Figure: ‘For Americans who aren’t open to cultivated meat: what are their barriers?’ GFI, 2025; Figure: ‘For Americans who aren’t open to mycoprotein-based meat: what are their barriers?’ GFI, 2025
60 “Lidl freut sich über eine positive Resonanz der Kunden, die mit einem Anstieg der verkauften veganen Artikel um über 30 Prozent seit der Preisanpassung vor einem halben Jahr einhergeht.” Translation: Lidl is pleased with the positive response from customers, which has been accompanied by an increase in the number of vegan items sold by over 30 percent since the price adjustment six months ago. Lidl, 2024
61 “The average German ate 52 kilograms of meat last year, down around 4.2 kilograms from 2021 levels and the lowest since the government started tracking meat consumption in 1989.” Just Food, 2023; “People in the UK consumed less meat last year than at any point since records began in the 1970s, in a trend driven by the cost of living crisis, the continued impact of Covid and broader lifestyle changes.” The Guardian, 2023; "Furthermore, concerns over the environment and climate change will result in consumers paying further attention to the production process and products’ origin. Consumers habits will also be driven by health considerations as well as convenience. Overall, EU meat per capita consumption is expected to drop from 69.8kg in 2018 to 67kg by 2031." European Commission, 2021
62 “If both Beyond Beef and Impossible Burger were available for $1/lb less, the combined plant-based share for regular meat consumers would increase from 2% to nearly 5%. Those declaring an alternative diet would have a larger combined plant-based selection rate of 31% (vs. a base of 25%).” Tonsor, Lusk & Schroeder, 2022
63 “Going further, the median WTP of $7.74 for a Beyond Meat Burger meal indicates the typical person would pay $1.11 more for a beef burger meal.” Tonsor, Lusk & Schroeder, 2022
64 “Concern that plant-based meat is ‘ultra-processed’ is widespread” Chapman, 2023; “How lab-grown meat became part of America’s culture wars” The Economist, 2024; “Thus, from various perspectives, meat is symbolic of status.” Chan and Zlatevska, 2019
65 “In countries with high meat consumption, altering social norms is also important” and “The food industry should make sure that plant-based meat alternatives are of similar nutritional value to meat; otherwise, there might be a backlash against highly processed plant-based meat alternatives due to their lack of healthiness” Siegrist and Hartmann, 2023; “Furthermore, incomplete safety assessments and a lack of clear regulatory guidelines confuse the food industry and hamper progress.” Malila et al., 2024 “In general, the following drivers of acceptance consistently show to be relevant for the acceptance of various alternative proteins: motives of taste and health, familiarity, attitudes, food neophobia, disgust, and social norms.” Onwezen et al., 2021
66 “About 2.79% of households only purchased PBMAs [plant-based meat alternatives]. About 86% of PBMA buyers also bought ground meat; however, PBMA buyers spent about 13% less on ground meat.” Neuhofer & Lusk, 2022
67 “Results suggest that increasing visibility, accessibility, affordability and availability of plant-based products led to increased sales, with evidence of lasting effects. No significant changes in meat sales were observed.” Trewern et al., 2022
68 “If Beyond Meat was available for $1/lb less, regular meat consumers would slightly increase (3% vs. 1%), their rate of selection with this increase coming more at the expense of Chicken Breast than any other item” Tonsor, Lusk, and Schoeder, 2022
69 We focus on the U.S. because we are less familiar with the politics of alt proteins in the other countries that GFI works in.
70 “...on April 30, 2021, Representative Dan Wolgamott (DFL-St. Cloud) and Senator Carrie Ruud (R-Breezy Point) introduced legislation (SF 2483 and HF 2583) that, if enacted into law, will invest in research and development to advance the plant-based food industry in Minnesota.” GFI, 2021; regulatory framework: “In 2019, FSIS and FDA established a formal agreement on how we would use our regulatory tools to help ensure that foods comprising or containing cultured animal cells entering the U.S. market are safe and properly labeled.” USDA, n.d.
71 GFI, 2022.
72 Food Biomanufacturing for National Security. GFI, 2026
73 “A geopolitical case for meat made without livestock may sound improbable. It isn’t.” Friedrich in Foreign Policy, 2026
What Is GFI’s Cost-Effectiveness?
GFI’s Cost-Effectiveness for Climate Change Mitigation
In 2022, as a rough plausibility check, we developed a cost-effectiveness analysis (CEA) to estimate the cost-effectiveness of GFI’s historical work on increasing funding for alt protein R&D (in terms of dollars per metric ton of CO2-equivalent (CO2e) reduced or avoided). We lightly updated the worst-case scenario of this model in 2024 (see Update log sheet). The model estimates the effect that GFI’s existence from 2016 to 2022 is expected to have on emissions from 2022 onward, absent any additional work from GFI after 2022. We use this outcome as a proxy for the cost-effectiveness of donations to GFI in 2025 or 2026. This CEA includes highly subjective guess parameters and should not be taken literally. In particular, we estimate the impact of GFI’s activities on changing the probability that a high-innovation scenario would occur instead of a low-innovation scenario and estimate what cultivated meat production may look like from 2020 to 2040.
Overall, our analysis estimates that GFI’s work is highly cost-effective.74 We have low confidence in the ability of our CEA to estimate GFI’s general cost-effectiveness, but we generally view it as a slight positive input into our overall assessment of GFI.75 See below for a high-level explanation and the model itself for additional notes and citations.
- Costs: We use GFI’s budget from 2016 to 2022.
- Avoided greenhouse gasses: Our analysis relies on results from an existing model that focuses on finding the difference in emissions between low- and high-innovation alt protein scenarios.76 We adjust our own model’s estimate for livestock production upward under the high-innovation scenario because we believe the original model’s estimates for cultivated meat production may have been too optimistic.77 Also, because the original model’s low-innovation scenario assumes a case where R&D is only driven by market forces, we adjust this scenario’s livestock production downward because alt proteins already receive public funding, and our best guess is that this will continue to be true.78 Using these new projections, we use available data to estimate a conversion factor between emissions and livestock production. We then use this factor to estimate the difference in emissions between the two scenarios based on our projections of livestock production.
- Effectiveness: We estimate GFI changed the probability of alt protein R&D moving from low- to high-innovation by a small percentage between 0.1% and 1.5%. We assume a small percentage, given the many players working in alt proteins. We also assume GFI’s growing emphasis on international R&D would be as effective as its historical work and, therefore, did not adjust for the marginal donation going to international instead of U.S.-based efforts. Next, we multiply this percentage by the difference in cumulative emissions between the two scenarios to calculate GFI’s expected value. We divide the expected value by GFI’s budget from 2016 to 2022 to estimate cost-effectiveness.
Results: Our best guess for GFI’s cost-effectiveness is $2.98 per metric ton of CO2e in expectation (range: $0.68 to $192). We also input our calculations into a Guesstimate model and found similar results. We have low confidence in our CEA's ability to estimate GFI’s marginal cost-effectiveness (see Key uncertainties and open questions section).
GFI’s Cost-Effectiveness for Reducing Biodiversity Loss
Because there is no straightforward outcome variable to measure and compare biodiversity benefits, we did not perform a cost-effectiveness analysis of GFI’s impact on reducing biodiversity loss. However, we see several qualitative arguments in support of GFI’s cost-effectiveness for reducing biodiversity loss.
Firstly, we expect GFI to be a cost-effective biodiversity nonprofit based on the model that we developed of GFI’s climate change mitigation cost-effectiveness. Since GFI’s theory of change for reducing habitat loss is mostly the same as its theory of change to reduce climate change, we expect that GFI is a cost-effective biodiversity nonprofit given that the nonprofit is cost-effective for climate change mitigation. In both cases, our understanding is that reducing global meat consumption is an important lever to make progress toward these global challenges.
Secondly, we believe that GFI’s focus on alternative proteins significantly contributes to the organization’s cost-effectiveness. In our strategy report on reducing biodiversity loss, we identified advocating for alt protein policy and research as one of the most promising strategies to reduce habitat loss and its associated biodiversity loss. Because GFI’s work concentrates exclusively in this area, its cost-effectiveness is not diminished by engagement in other food systems or biodiversity work that might be less favorable in terms of scale, feasibility, and funding need.
-----
74 As a heuristic to guide our research prioritization, we consider something to plausibly be within the range of cost-effectiveness we would consider for a top recommendation if its estimated cost-effectiveness is within an order of magnitude of $1/tCO2e (i.e., less than $10/tCO2e).
75 We describe our confidence as low/medium/high to increase readability and avoid false precision. Since these terms can be interpreted differently, we use rough heuristics to define them as percentage likelihoods our takeaway (i.e., [not] plausibly within the range of cost-effectiveness we would consider recommending) is correct. Low = 0-60%, medium = 60-80%, high = 80-100%.
76 ClimateWorks Foundation, 2021
77 Our take on cultivated meat production: We assumed that cultivated meat production would remain low through 2051 based on a report by Rethink Priorities. "Despite some variation, the majority of probabilities were for low production volumes. The aggregated probabilities from our panel include a 54% probability that less than 100,000 metric tons of cultured meat (where >51% of the “meat” is produced directly from animal cells) will be produced and sold at any price in a 12-month period before the end of 2051." Dullaghan, 2022; Upward adjustment: We adjusted estimates for conventional livestock production upward by assuming that overall meat production would remain the same but cultivated meat production would remain low. Therefore, we adjusted cultivated meat production downward and assumed that the difference in meat production would be conventional meat production. For more information, please see the Adjusted high-innovation scenario sheet.
78 We adjusted livestock production under the low-innovation scenario downward by assuming it would be the average between the low-innovation scenario and the adjusted high-innovation scenario. For more information, please see the Livestock production sheet.
Is There Room for More Funding?
GFI’s Current Funding Status
GFI has experienced roughly linear growth in its annual expenses from $13 million in 2020 to $39 million in 2025, as shown in Figure 7. GFI’s revenue has been less regular, with several multi-year commitments by relatively large donors in 2021 and 2023 contributing to a large part of GFI’s multi-year revenue. GFI’s financial planning includes a budget of $37.1 million for 2027, so the organization would stay roughly the same size as it was in 2024.
GFI’s expenses and revenue per year

GFI said that if it does not reach its funding goals, it would have to:
- Slow the growth of its recently launched offices in Japan and Korea, which are important R&D and commercial hotspots for alt proteins.
- Scaling back its research grants program.
- Reduce market research and production of key reports.
- Scale back other workstreams.
GFI has received support from some major funders and influencers. For example, the Farm Animal Welfare program by Coefficient Giving has granted GFI a total of eight grants amounting to $32.5 million USD since 2016, the latest of which amounted to $5.4 million USD in September 2025.80 Additionally, GFI was recommended by Animal Charity Evaluators (ACE) as a top animal welfare organization from 2016 to 2020 and again from 2022 to 2024.81 The Bezos Earth Fund also awarded GFI $5.5 million in 2023 to act as a scoping partner for its food strategy and $9.8 million in 2024 for a two-year grant to support its work to strategically build the innovation ecosystem for alt proteins.82 We think it is likely that GFI will continue to receive funding from some subset of these funders and will also gain more funders as it becomes more well-known.
Fundraising Goal and Funding Need
GFI is currently fundraising for its 2027 budget goal of $37.1 million. As of October 2026, it has raised $18.2 million for 2027, meaning that the organization’s remaining funding need for 2027 is $18.9 million. GFI is facing a challenging fundraising environment and has not been able to grow in the last few years, despite promising expansion priorities. We describe these priorities in the section below.
As of October 2026, GFI is also still fundraising to fill its remaining 2026 funding gap of $5 million to $10 million. We expect much of this gap to be closed through the end of 2026, when GFI typically sees a fundraising spike.
Table 1: GFI’s fundraising goals and funding gap for 2027, as of early October 2026

How Would GFI Spend Additional Funds in 2027 and Beyond?
If GFI meets or exceeds its fundraising targets, it would expand its work in the following areas:
- Continuing or accelerating its expansion in Japan, Korea, and China. GFI sees these markets as important expansion opportunities.
- Expanding its work in Europe. In particular, GFI sees significant opportunities to expand its work in Switzerland, France, the Nordics (especially Denmark, Sweden, and Norway), and the Netherlands.
- Filling gaps in the technical roadmap for alternative proteins, including capturing cell lines and other IP from companies and making it open access.
- Advancing an alternative protein data library to provide the large, standardized, accessible datasets needed to take advantage of recent breakthroughs in artificial intelligence.
Additionally, GFI APAC (its Asia-Pacific affiliate) is working to apply for approval to set up a representative office of its Singapore entity in mainland China. This will be an independent NGO, or INGO, which will be well placed to build partnerships and mission impact in China. GFI APAC expects that this INGO could position alt proteins as a solution for China’s targets on food self-sufficiency and economic growth.
We think that GFI’s plans to expand its work outside the U.S. and through location-agnostic research grants provides a likely impact expansion opportunity which reduces risk to changing political support in the U.S. As visible in Figure 8, these initiatives currently constitute a minor part of GFI’s overall budget across affiliates.
Expenses of GFI in 2025 by category

We think that GFI can productively absorb additional funding at present. As it continues to build its successful track record, GFI may be able to resume its previous growth trajectory without financial support or recommendations from Giving Green. On the other hand, GFI’s ambitious mission and growth plans could suggest that its activities continue to outpace available funding.
GFI has also indicated that its recommendation by Giving Green has helped its advocacy efforts for alt proteins as a climate solution and helped diversify its funding base. We think it is possible that this improved advocacy helped GFI attract more funding from climate-focused donors compared to what it would have received otherwise, but we are unsure. We hope that our recent recommendation of GFI as a Top Biodiversity Nonprofit helps to establish alt proteins as a biodiversity solution.
Alt Proteins Need Philanthropic Support Despite Venture Capital Investments
While venture capital (VC) invests in alternative proteins, we still think this field is in need of philanthropic support. VC funding for alt proteins was around $881 million in 2025.83 This is considerably lower than VC investment from 2021, which reached a record $6 billion.84 Experts we spoke to said alt protein R&D still requires philanthropic support due to:
- Inefficient spending: Private sector spending tends to go toward overhead and duplicative research protected as private intellectual property. In contrast to VC funding, philanthropy can fund open-access research without a profit motive.
- Risk protection if private sector spending dips: VC interest in plant-based meats may wane as the field matures because VCs often prefer funding novel ideas over infrastructure. Additionally, investors may be alarmed by the plateau in U.S. plant-based meat sales between 2020 and 2021.85
- Products are not yet competitive with meat: Many alt proteins, especially cultivated meat, are still at an early stage of technological development and have not yet reached taste and price parity with meat. Because alt proteins provide public goods such as climate benefits that markets do not reward, we think private investment alone is unlikely to close this taste and price gap quickly. Philanthropy can help fill this gap directly, and by advocating for more public R&D funding.
Because they are still in the early stages of technological development, alt proteins would benefit from additional research, development, and demonstration (RD&D) funding to de-risk private-sector investment and accelerate deployment. There has been a precedent of public funding to support both agriculture and climate mitigation, though so far, public funding for agriculture is mostly spent on emissions-intensive farming practices.86 We have observed more nonprofits working to support government investment than private-sector investment, but think this is appropriate, given that the market for alt proteins is still nascent.
Our view is that the private sector is still interested in engaging in alt proteins, but is now more realistic about the challenges of entering the market. We think there is a smaller pool of follow-on funding available to alt proteins, but that it is still available to cutting-edge products.
-----
79 The trendline assumes linear growth. The 990 revenue report includes some pledges and grants that are not received until future years. For example, in 2021 and 2023, GFI received large multi-year commitments. The full commitments were included in GFI’s 990 filings (as required), but the actual donations were fulfilled over the following 1-2 additional years.
80 Based on the overview of grants in the Farm Animal Welfare program on the Coefficient Giving website. Data was retrieved on October 12th, 2026.
81 “GFI was a Recommended Charity from November 2016 to November 2021. They were recommended again in 2022.” Animal Charity Evaluators, 2022
In 2024 and 2025, GFI deferred its participation in the ACE review process because the review process takes a substantial amount of time as it would involve a review of all of its seven affiliates.
82 Bezos Earth Fund award: “Accelerating Alternative Proteins for a Sustainable Food System. Date awarded: 2/2023. Amount granted: $5.5M.” Bezos Earth Fund, 2023; “Amount granted: $9.8M” “with a two-year grant focused on building the innovation-ecosystem required to fuel this field.” Bezos Earth Fund, 2024
83 Figure: GFI, 2026
84 “And while the space raised a record $6.0 billion of VC funding in 2021, the $883.8 million raised in Q1 2022 is well below this trend, with the capital-intensive nature of these businesses potentially making it even harder to raise capital in the current environment.” PitchBook, 2022
85 US plant-based meat and seafood sales increased by 46% between 2019 and 2020, jumping from $957M to $1.4B. However, sales were roughly the same in 2021 as it was in 2020 (“Dollar sales of plant-based meat were flat in 2021 over 2020, which was a record year of growth”). Potential explanations for the plateau include pandemic impacts and inflation, which increased the cost of conventional meat and skewed comparisons between how much US consumers spent on conventional meat and alt proteins. GFI, 2022
86 “Less than a quarter of transfer payments are used to grow the kinds of foods that are good for human health and the environment, and which a healthy and sustainable food system would need much more of: fruits, vegetables, legumes and nuts.” Springmann, 2022
Are There Major Co-Benefits or Potential Risks?
Co-Benefits
- Improved farm animal welfare: Over 100 billion land-animals are killed for animal products each year.87 A shift in protein sources toward more alt proteins would lead to fewer animal deaths, and reduced animal suffering from practices such as lack of space, artificial insemination, increased risk of disease and lameness, and slaughter.88
- Reduced antimicrobial resistance and risk of zoonotic disease: Animal agriculture uses 73% of global antibiotics, and the United Nations Environment Programme states that “the widespread and excessive use of antibiotics in animal agriculture has been linked to the rise of antimicrobial resistance in both animals and humans.”89 It also found that the expansion of animal agriculture has led to the increased risk of zoonotic disease, which causes 70% of emerging infectious diseases and almost all known pandemics.
- Lower land, water, and fertilizer demand: Producing conventional proteins is generally more resource-intensive than plant-based alternatives. For example, plant-based alt proteins use 76-89% less water and 41-98% less land than farmed meat.90 Because fewer crops are involved, alt proteins also require less fertilizer and lower pesticide inputs than livestock products.91
- Lowered health risks associated with livestock production: Livestock production facilities increase some health risks for workers and people who live nearby.92 Alt proteins could potentially lower these health risks by disrupting livestock production. Similarly, fewer workers may be harmed if alt protein production is physically safer than livestock production.93
Potential Risks
- Socioeconomic implications of shifting away from traditional livestock production: A major shift away from traditional livestock production would likely impact people’s livelihoods. For example, scaling alt proteins would shift the labor workforce “from one largely based on farmers, farmworkers, meat processors, and veterinarians, to one based on chemists, cell biologists, engineers, and factory and warehouse workers.”94 Overall, we think increased alt protein production probably decreases some types of jobs and increases others, but we are unsure about the net change in jobs and where these jobs will be located.
- Agri-food industry consolidation: Our understanding is a small number of companies hold most of the power in the U.S. agri-food industry. Compared to interventions focusing on transformative change, alt protein production may reinforce current food system dynamics.95 GFI responds that this is a strong argument for public sector funding, which is likely to create a broader ecosystem of participants.
- Potential micronutrient deficiencies: Diets excluding animal products may increase the risk of certain micronutrient deficiencies (for example, vitamin B12, zinc, and calcium).96 Although some alt protein producers add these nutrients back to their products, adding missing nutrients in isolation may underestimate the complexity and health benefits of eating whole foods.97 We note that cultivated meat would likely have the same nutrient profile as conventional meat.
-----
87 “More than 100 billion animals are killed for meat and other animal products every year.” OWID, 2024
88 “The genetic component underlying milk yield has also been found to be positively correlated with the incidence of lameness, mastitis, reproductive disorders and metabolic disorders” European Food Safety Authority, 2009
89 “The widespread and excessive use of antibiotics in animal agriculture has been linked to the rise of antimicrobial resistance in both animals and humans; globally, 73 percent of all antimicrobials sold are used in livestock agriculture. Animal agriculture expansion and industrialization… have also been linked to increased risk of zoonoses emergence. The majority (70 percent) of emerging infectious diseases and almost all known pandemics (e.g. influenza, HIV/AIDS, COVID-19) are zoonoses.” UNEP, 2023
90 “For every 100 grams of protein, plant-based alt-proteins have a water footprint that is 76–89 percent smaller than the water footprint of farmed meat.” “Per 100 grams of protein, plant-based alternative proteins have a median land use that is 41–98 percent smaller than the median land use of farmed meat.” CSIS, 2023
91 “Similarly, because there is no animal waste to discharge and fewer crops and fertilizers are needed, alternative proteins reduce the discharge of nitrogen and phosphorus” GFI, n.d.
92 Health outcomes from living near livestock production facilities: “We reviewed the literature published since 2000 and identified four health outcomes consistently and positively associated with living near IFAP: respiratory outcomes, methicillin-resistant Staphylococcus aureus (MRSA), Q fever, and stress/mood.” Casey et al., 2015. Downstream pollution: “...the recent growth of concentrated animal feeding operations (CAFOs) presents a greater risk to water quality because of both the increased volume of waste and to contaminants that may be present (e.g., antibiotics and other veterinary drugs) that may have both environmental and public health importance. Based on available data, generally accepted livestock waste management practices do not adequately or effectively protect water resources from contamination with excessive nutrients, microbial pathogens, and pharmaceuticals present in the waste.” Burkholder et al., 2007
93 “For workers, too, plant-based processing factories like Rebellyous are much better places to be employed than slaughterhouses. Making “meat” out of pea protein or soy is far less dangerous and grueling than the worst slaughterhouse jobs, which require workers to break down carcasses in cold and dark factories, working shoulder-to-shoulder, a profession with some of the highest injury and mortality rates.” The Breakthrough Institute, 2022.
94 “A rapid transformation of the agricultural marketplace from farmed to cell-based meat production—and, to a lesser extent, plant-based substitute production—could entail a significant overhaul in the labor workforce involved in protein production, from one largely based on farmers, farmworkers, meat processors, and veterinarians, to one based on chemists, cell biologists, engineers, and factory and warehouse workers.” Santo et al 2020
95 “Addressing concentration of power is all the more urgent in the ‘protein’ sector, where horizontal integration and huge capital influxes are rapidly reshaping the terrain and influencing public discourse.” iPES Food, “The Politics of Protein" 2022
96 “Following a vegan diet may result in deficiencies in micronutrients (vitamin B12, zinc, calcium and selenium) which should not be disregarded.” Bakaloudi et al., 2021
97 “As whole foods contain hundreds-to-thousands of compounds that act synergistically to impact human health, adding synthetic nutrients to food sources often does not confer similar benefits compared to when these nutrients are ingested as phytochemically and biochemically-rich whole foods—whether it be plant or animal foods” Santo et al 2020.
Key Uncertainties and Open Questions
Our key uncertainties and open questions related to Giving Green’s theory of change for GFI are described below.
- GFI’s future fundraising levels: After several years of rapid growth, GFI’s budget has leveled off, and we are uncertain whether it will be able to raise enough to grow again or keep its current size. GFI’s annual expenses grew from $13 million in 2020 to $35 million in 2024, but its 2027 budget of $37.1 million would keep it roughly the same size, and it did not meet its three-year fundraising goal for 2023 to 2025. GFI may continue falling short of its fundraising goals, leaving a large remaining funding gap like the ones we found in our 2025 and 2026 assessments. On the other hand, we think a substantial increase in farm animal welfare donations from newly wealthy AI-industry donors is possible, and some of this new funding may go to alt proteins. Lewis Bollard, who leads Coefficient Giving’s farm animal welfare program (a long-standing GFI funder), reports that these donors have already given tens of millions of dollars this year. He lists reviving alt proteins as one of the priorities this money could enable.98 If a meaningful share of this funding reaches GFI, its room for more funding could shrink considerably. We are uncertain how large this wave of funding will be, what share will go to alt proteins, and how much of that share will go to GFI.
- The ability of alt proteins to compete with conventional meat in taste and price: We have medium certainty that alt proteins can achieve taste and price parity with meat. Recent progress makes us cautiously optimistic. Production costs for cultivated meat appear to have fallen faster than earlier analyses expected, and the best plant-based products are approaching taste parity with their meat counterparts. However, private investment in alt proteins has dropped sharply since its 2021 peak. If it does not recover, we doubt alt proteins will have enough funding to reach parity. That makes government and philanthropic support more important to improve taste and price.99
- Scalability of cultivated meat: We have several uncertainties about the scale-up of cultivated meat and, therefore, its ability to displace demand for conventional meat. These include its production costs, ability to overcome the technical and process development challenges to scale up, its political tractability, and threats posed by bans on cultivated meat.100 For these reasons, we advocate for a strategy that includes all types of alt proteins to hedge against the risk that cultivated meat is unable to scale.
- Social and cultural perceptions of alt proteins: Factors like social and cultural perception influence the acceptance of alt proteins, and efforts to improve taste and price will not address these barriers. We believe that current social and cultural barriers to alt protein acceptance are substantial and could stand in the way of increased consumption. For example, we think alt proteins have often been portrayed as less healthy and more processed than conventional meat. We also think it is highly likely that players in the livestock industry will heighten that perception to reduce alt proteins’ competitiveness. People we have spoken to who work in alt proteins are familiar with these issues, and there are ongoing efforts to increase alt protein acceptance. GFI engages in the nutrition and ultra-processing debate where they emerge as a barrier (e.g., legislation that may define alt proteins as ultra-processed foods) or where they provide opportunities to engage key stakeholders (e.g., sharing bioavailability studies of alt proteins with government stakeholders, or researching and disseminating of narratives that resonate with consumers on plant-based meat’s nutritional benefits). We think work in this area may improve competitiveness, but it is too early to tell.
- The carbon sequestration rate of freed-up land (e.g., former pasture and croplands): There will be some delay before people can restore land previously used for livestock production and before the land begins storing carbon. We are unsure how much of the freed-up land is usable for carbon sequestration, how much carbon can be stored in total, and how long carbon can be stored.
- GFI’s effectiveness for reducing marine biodiversity loss: We primarily evaluated GFI’s contribution to reduced biodiversity loss because of its impacts on reduced land use change. GFI also works on alternative seafood, which can be made using the same technologies as plant-based and cultivated meat. We do not know how well GFI compares to a best-in-class marine biodiversity organization.
-----
98 “Spent well, I think the new [AI windfall] funds could: [...] Revive alternative proteins” Bollard, 2026
99 See assumption 2 (“Alt proteins can achieve price and taste parity with meat”) in our Scaling Alternative Proteins strategy report.
100 Cultivated meat bans: “Alabama became the second U.S. state to ban lab-grown meat, joining Florida which earlier this month outlawed the alternative protein.” “Officials in other states including Kentucky, Arizona, West Virginia and Tennessee have similar measures cooking” USA Today, 2024; scale-up challenges: “Low growth rate, metabolic inefficiency, catabolite inhibition, and shear-induced cell damage will all limit practical bioreactor volume and attainable cell density. Equipment and facilities with adequate microbial contamination safeguards have high capital costs. The projected costs of suitably pure amino acids and protein growth factors are also high.” Humbird, 2021
Bottom Line and Next Steps
We classify GFI as a Top Climate Nonprofit and Top Biodiversity Nonprofit. We see GFI as a leader in alternative protein thought leadership and action. We believe GFI’s advocacy has helped to secure hundreds of millions in public funding for alt proteins and create an ecosystem of support around alt proteins, accelerating improvements that could shift consumers to more climate- and biodiversity-friendly diets. Though we generally think GFI’s work is promising, we think the impact of alt proteins on global livestock production is still uncertain. In particular, we are unsure about alt proteins’ ability to compete with meat in taste and price, the social and cultural acceptance of alt proteins, and the scalability of cultivated meat. We will continue monitoring these uncertainties.
Key accomplishments include:
- Playing a substantial role in the regulatory approval of cultivated meat in the U.S. and Singapore.
- Partnering with the Bezos Earth Fund to open three alternative protein research centers, worth $90 million.
- Supporting JBS’s $100 million investment in cultivated meat.
- Providing input to include alternative proteins in several national plans and funding mechanisms, such as India’s bioeconomy plan, the EU’s Farm to Fork strategy, and the U.K.’s National Alternative Protein Innovation Centre.
Explore ways to give to GFI and more.
GFI is a registered nonprofit in the U.S. GFI has 501(c)(3) and 501(c)(4) entities. As Giving Green is itself a charitable, tax-exempt organization, we are only offering an opinion on the charitable activities of GFI’s 501(c)(3) arm. This is a non-partisan analysis (study or research) and is provided for educational purposes.
Acknowledgments
Enzia Schnyder researched and wrote this report, and Greer Gosnell managed and oversaw the research. Soemano Zeijlmans and Kim Huynh contributed to various sections. Dan Stein provided valuable feedback on report drafts. This work has benefited greatly from feedback provided by a variety of external advisors, experts, and reviewers throughout the research process. Giving Green is grateful for those who shared their time, experience, and ideas. All opinions remain those of Giving Green alone, and any remaining errors are our own.
Support Our Work
Giving Green Fund
One fund. Global impact. One hundred percent of your gift supports a portfolio of high-impact climate organizations, vetted by our research.
Best for:
Donors who want the simplest way to impact multiple climate solutions.
Top Climate Nonprofits
Meet the organizations on Giving Green’s list of high-impact nonprofits working to decarbonize our future, identified through our rigorous research.
Best for:
Donors who want to give directly and independently.
Support Our Work
We thoroughly research climate initiatives so you can give with confidence. For every $1 we receive, our work unlocks another $25.90 for effective climate solutions.
Best for:
Donors who want to amplify their impact through research.













.webp)
.webp)

.webp)

%20(1).webp)



.webp)
.webp)

.webp)




.webp)

.webp)


.webp)
.webp)

.png)















.webp)







.webp)




.jpeg)

.webp)
.webp)




.webp)



.webp)

%20(1).png)
.webp)

.webp)


.webp)




.webp)

